Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs Carbetocin for PPH Prevention in Elective C-Sections
NCT03651882Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Aug 2018
- Primary completion
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Oxytocin Arm with Carbetocin Arm (2 arms). Primary endpoint: Incidence of women with a delta hemoglobin ≥ 30g/l at 48 hours. Started Aug 2018; status: completed.
02
Drugs
oxytocincarbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03651882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651882.